Market Cap 161.30B
Revenue (ttm) 62.58B
Net Income (ttm) 7.77B
EPS (ttm) N/A
PE Ratio 9.37
Forward PE 9.60
Profit Margin 12.42%
Debt to Equity Ratio 0.74
Volume 31,174,400
Avg Vol 44,044,414
Day's Range N/A - N/A
Shares Out 5.70B
Stochastic %K 72%
Beta 0.34
Analysts Sell
Price Target $28.60

Company Profile

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands;...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 212 733 2323
Address:
66 Hudson Boulevard East, New York, United States
Lowkeyoptions
Lowkeyoptions Aug. 28 at 12:55 AM
$BHVN $PFE hmmm!! biohaven pfe Pfizer Inc. completed its acquisition of Biohaven Pharmaceutical Holding Company Ltd. on October 3, 2022, for approximately $11.6 billion in cash. [1, 2] Deal Terms Cash Payment: Biohaven shareholders received $148.50 per share in cash. New Biohaven Spin-off: Shareholders also received 0.5 of a share in a new separate company ("New Biohaven") that kept the non-CGRP pipeline compounds. Total Value: The cash portion of the transaction was valued at $11.6 billion. [1, 2] Key Products & Assets NURTEC® ODT (rimegepant): An innovative pill approved to treat and prevent migraines in adults. VYDURA®: The European Union trade name for rimegepant. CGRP Portfolio: A collection of calcitonin gene-related peptide receptor antagonists designed for neurological diseases. [1]
0 · Reply
JBS_84
JBS_84 Aug. 27 at 11:52 PM
$PFE Positive articles so institutions can get short at a high price. They've no doubt took their positions by now, and you will begin seeing the price pullback followed by negative articles. I've said it before when everyone's saying it's going to 50, You sell when everyone's saying it's going to 20 buy. Simple.
0 · Reply
KilroyPicks
KilroyPicks Aug. 27 at 9:37 PM
$MIST - Rome wasn't built in a day. This drug is a specialty drug with a specific and relatively small patient base less than 1% of the US population. Also, this is Milestone's first drug so they are building relationships from scratch from doctors to the formulary channels. This will take a little longer to build than a drug from say Pfizer & $PFE or J&J $JNJ or Bristol-Myer Squib $BMY , those companies already have the relationships in place.
2 · Reply
focafoca99
focafoca99 Aug. 27 at 8:55 PM
$PFE got FDA approval for its XFG-adapted COVID-19 vaccine for seniors and high-risk adults. https://www.rapidticker.com/news/pfe-pfizer-and-biontech-receive-us-e396bc
0 · Reply
Outcomes
Outcomes Aug. 27 at 8:55 PM
$IBRX $MRNA $PFE $JNJ ......'why did I choose this career path? I am seeing so much carnage. I beg you. I am seeing so much autoimmunity developing. I've seen 4 men trying to conceive, not one single functioning sperm.' mRNA BAD. 'It is beyond all reasonable doubt' mRNA causes 'Turbo-cancers. And now, mRNA for cancer treatment. THE ULTIMATE HYPOCRISY. PSS KNOWS. https://x.com/ImBreckWorsham/status/2092973899935858784?s=20 SAVE THE CHILDREN. 🙏
5 · Reply
goguryo2000
goguryo2000 Aug. 27 at 8:35 PM
$PFE Recent Pipeline and Regulatory Updates Lyme Disease Vaccine: The European Medicines Agency (EMA) validated the Marketing Authorization Application for Pfizer and Valneva's joint Lyme disease vaccine candidate. Prostate Cancer Review: The FDA granted Priority Review for Pfizer's Talzenna combined with Xtandi to treat metastatic prostate cancer. Bladder Cancer Approval: The FDA approved Padcev plus Keytruda for muscle-invasive bladder cancer. Vitiligo Results: Pfizer announced positive Phase 3 topline results for Litfulo in patients suffering from nonsegmental vitiligo. Financial and Market Position Guidance: Management raised the 2026 revenue guidance midpoint by $500 million following steady non-COVID revenue recovery. Dividends: The company declared its third-quarter 2026 dividend while balancing cost-cutting initiatives to offset declining pandemic-era product sales.
0 · Reply
goguryo2000
goguryo2000 Aug. 27 at 7:50 PM
$PFE Happy with 28. Looking forward for 30. Happy trading.
1 · Reply
NorthOfSouth
NorthOfSouth Aug. 27 at 6:55 PM
$PFE This super f'd up market really started April 2025 when a certain individual made false claims about tariffs and crashed the markets...then repealed them and markets shot up...who loaded up at that time? Been pumped (AI) incessantly since then...Q: is when (after the major short positions have been established) will the plug be pulled? I know that I want a chair when the music stops...
2 · Reply
FlowAnomaly
FlowAnomaly Aug. 27 at 4:55 PM
$RVMD calls printing $MRNA $PFE $VSTM
0 · Reply
Loudermilk64
Loudermilk64 Aug. 27 at 4:05 PM
$PFE Pulling back up higher on the 1 week.
0 · Reply
Latest News on PFE
Pfizer Stock (PFE) Is a Buy despite Declining Revenue

2026-08-24T12:18:00.000Z - 3 days ago

Pfizer Stock (PFE) Is a Buy despite Declining Revenue


Pfizer, Valneva announce EMA validation for PF-07307405 MAA

2026-08-16T13:55:21.000Z - 11 days ago

Pfizer, Valneva announce EMA validation for PF-07307405 MAA

VALN


Pfizer (PFE) CEO Buys $1 Million of Company Stock

2026-08-14T18:45:04.000Z - 13 days ago

Pfizer (PFE) CEO Buys $1 Million of Company Stock


Pfizer Earnings Call Transcript: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 23 days ago

Pfizer Earnings Call Transcript: Q2 2026


Pfizer Earnings release: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 23 days ago

Pfizer Earnings release: Q2 2026


Pfizer Slides: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 23 days ago

Pfizer Slides: Q2 2026


Pfizer Quarterly report: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 23 days ago

Pfizer Quarterly report: Q2 2026


Pfizer Post Loss on Higher Revenue

Aug 4, 2026, 7:24 AM EDT - 23 days ago

Pfizer Post Loss on Higher Revenue


Options Corner: PFE Downgrade, Stock Slides Near 52-Week Low

Jul 6, 2026, 10:00 AM EDT - 7 weeks ago

Options Corner: PFE Downgrade, Stock Slides Near 52-Week Low


Pfizer Declares Third-Quarter 2026 Dividend

Jun 24, 2026, 3:52 PM EDT - 2 months ago

Pfizer Declares Third-Quarter 2026 Dividend


Pfizer dismissed from US states' drug price-fixing lawsuit

Jun 24, 2026, 10:51 AM EDT - 2 months ago

Pfizer dismissed from US states' drug price-fixing lawsuit


Pfizer's experimental drug misses main goal of lung cancer trial

Jun 22, 2026, 4:43 PM EDT - 2 months ago

Pfizer's experimental drug misses main goal of lung cancer trial


Pfizer CFO Dave Denton to step down, leave company in August

Jun 18, 2026, 6:52 AM EDT - 2 months ago

Pfizer CFO Dave Denton to step down, leave company in August


Pfizer Announces Chief Financial Officer Transition

Jun 18, 2026, 6:45 AM EDT - 2 months ago

Pfizer Announces Chief Financial Officer Transition


US FDA approves Pfizer's bleeding disorder drug for children

Jun 8, 2026, 6:49 AM EDT - 2 months ago

US FDA approves Pfizer's bleeding disorder drug for children


Pfizer Transcript: Study update

Jun 6, 2026, 11:00 AM EDT - 2 months ago

Pfizer Transcript: Study update


Pfizer Slides: Study update

Jun 6, 2026, 11:00 AM EDT - 2 months ago

Pfizer Slides: Study update


Pfizer Press release: Study update

Jun 6, 2026, 11:00 AM EDT - 2 months ago

Pfizer Press release: Study update


Pfizer Transcript: Jefferies Global Healthcare Conference 2026

Jun 3, 2026, 2:00 PM EDT - 3 months ago

Pfizer Transcript: Jefferies Global Healthcare Conference 2026


Lowkeyoptions
Lowkeyoptions Aug. 28 at 12:55 AM
$BHVN $PFE hmmm!! biohaven pfe Pfizer Inc. completed its acquisition of Biohaven Pharmaceutical Holding Company Ltd. on October 3, 2022, for approximately $11.6 billion in cash. [1, 2] Deal Terms Cash Payment: Biohaven shareholders received $148.50 per share in cash. New Biohaven Spin-off: Shareholders also received 0.5 of a share in a new separate company ("New Biohaven") that kept the non-CGRP pipeline compounds. Total Value: The cash portion of the transaction was valued at $11.6 billion. [1, 2] Key Products & Assets NURTEC® ODT (rimegepant): An innovative pill approved to treat and prevent migraines in adults. VYDURA®: The European Union trade name for rimegepant. CGRP Portfolio: A collection of calcitonin gene-related peptide receptor antagonists designed for neurological diseases. [1]
0 · Reply
JBS_84
JBS_84 Aug. 27 at 11:52 PM
$PFE Positive articles so institutions can get short at a high price. They've no doubt took their positions by now, and you will begin seeing the price pullback followed by negative articles. I've said it before when everyone's saying it's going to 50, You sell when everyone's saying it's going to 20 buy. Simple.
0 · Reply
KilroyPicks
KilroyPicks Aug. 27 at 9:37 PM
$MIST - Rome wasn't built in a day. This drug is a specialty drug with a specific and relatively small patient base less than 1% of the US population. Also, this is Milestone's first drug so they are building relationships from scratch from doctors to the formulary channels. This will take a little longer to build than a drug from say Pfizer & $PFE or J&J $JNJ or Bristol-Myer Squib $BMY , those companies already have the relationships in place.
2 · Reply
focafoca99
focafoca99 Aug. 27 at 8:55 PM
$PFE got FDA approval for its XFG-adapted COVID-19 vaccine for seniors and high-risk adults. https://www.rapidticker.com/news/pfe-pfizer-and-biontech-receive-us-e396bc
0 · Reply
Outcomes
Outcomes Aug. 27 at 8:55 PM
$IBRX $MRNA $PFE $JNJ ......'why did I choose this career path? I am seeing so much carnage. I beg you. I am seeing so much autoimmunity developing. I've seen 4 men trying to conceive, not one single functioning sperm.' mRNA BAD. 'It is beyond all reasonable doubt' mRNA causes 'Turbo-cancers. And now, mRNA for cancer treatment. THE ULTIMATE HYPOCRISY. PSS KNOWS. https://x.com/ImBreckWorsham/status/2092973899935858784?s=20 SAVE THE CHILDREN. 🙏
5 · Reply
goguryo2000
goguryo2000 Aug. 27 at 8:35 PM
$PFE Recent Pipeline and Regulatory Updates Lyme Disease Vaccine: The European Medicines Agency (EMA) validated the Marketing Authorization Application for Pfizer and Valneva's joint Lyme disease vaccine candidate. Prostate Cancer Review: The FDA granted Priority Review for Pfizer's Talzenna combined with Xtandi to treat metastatic prostate cancer. Bladder Cancer Approval: The FDA approved Padcev plus Keytruda for muscle-invasive bladder cancer. Vitiligo Results: Pfizer announced positive Phase 3 topline results for Litfulo in patients suffering from nonsegmental vitiligo. Financial and Market Position Guidance: Management raised the 2026 revenue guidance midpoint by $500 million following steady non-COVID revenue recovery. Dividends: The company declared its third-quarter 2026 dividend while balancing cost-cutting initiatives to offset declining pandemic-era product sales.
0 · Reply
goguryo2000
goguryo2000 Aug. 27 at 7:50 PM
$PFE Happy with 28. Looking forward for 30. Happy trading.
1 · Reply
NorthOfSouth
NorthOfSouth Aug. 27 at 6:55 PM
$PFE This super f'd up market really started April 2025 when a certain individual made false claims about tariffs and crashed the markets...then repealed them and markets shot up...who loaded up at that time? Been pumped (AI) incessantly since then...Q: is when (after the major short positions have been established) will the plug be pulled? I know that I want a chair when the music stops...
2 · Reply
FlowAnomaly
FlowAnomaly Aug. 27 at 4:55 PM
$RVMD calls printing $MRNA $PFE $VSTM
0 · Reply
Loudermilk64
Loudermilk64 Aug. 27 at 4:05 PM
$PFE Pulling back up higher on the 1 week.
0 · Reply
StUngarjr
StUngarjr Aug. 27 at 4:04 PM
$PFE l’m writing this from the hospital. I just woke up after a 22 year coma. I see the stocks at 28 which it was when I went in to the coma. Question, how many times have we split? I can’t see my brokerage account yet, but must’ve split like 10 times since? So I have 10,000 shares not 1000?
0 · Reply
marketlimit
marketlimit Aug. 27 at 3:07 PM
$PFE back to $21 we go…
0 · Reply
Micheal_Pothead
Micheal_Pothead Aug. 27 at 2:53 PM
$PFE tried to sell puts at 0.30 and they got to 0.27 🫩
0 · Reply
INEEDMONEY87
INEEDMONEY87 Aug. 27 at 1:41 PM
$PFE had me nervous, i actually put a stop up for the first time in 6 months....
0 · Reply
Micheal_Pothead
Micheal_Pothead Aug. 27 at 1:11 PM
$PFE do we suck again?
3 · Reply
NorthOfSouth
NorthOfSouth Aug. 27 at 1:07 PM
$PFE sell, hold, buy ...You have 3 choices
0 · Reply
Samishere
Samishere Aug. 27 at 1:02 PM
2 · Reply
NRG8
NRG8 Aug. 27 at 12:56 PM
$BRK.A $WMT $LLY $XOM $PFE Do you know of a more undervalued company than BZUN which is profitable, growing and has low debt? BZUN share price is $2.9 and today the company has raised FY28 forecast EPS to $1.79
1 · Reply
JuggernautRaider
JuggernautRaider Aug. 27 at 10:34 AM
$NUVB sold my shares: investing elsewhere! Good luck and Godspeed 🏃‍♂️ $GSK $NVS $PFE 💊 Adios mis amigos. Vaya Con Dios! 🙏 📕
1 · Reply
Samishere
Samishere Aug. 27 at 2:32 AM
2 · Reply
Micheal_Pothead
Micheal_Pothead Aug. 26 at 9:42 PM
$PFE market is back to pumping AI
1 · Reply
Jtlo
Jtlo Aug. 26 at 9:10 PM
$PFE tomorrow load up 27 stock
1 · Reply